Aridica Corporation Receives Colorado State Grant

Aridica Corporation is pleased to announce it has been awarded an Early-Stage Capital and Retention grant through the Colorado Office of Economic Development and International Trade (OEDIT) Advanced Industries Accelerator program. This funding will help further the development of Aridica's blood separation technology to radically simplify the isolation of human immune cells.

The Early-Stage Capital and Retention grant supports businesses commercializing innovative and disruptive technologies in the advanced industries that will be created or manufactured in Colorado. These grants help promote the growth and sustainability of advanced industries across the state by driving innovation and commercialization that move this vital part of the Colorado economy forward.

Aridica Corporation was awarded $238,000 to support the design, fabrication and testing of Aridica's first product, an easy-to-use blood separation technology. This funding will prepare Aridica for the company's next stage of commercialization and solidify Aridica's footprint in Colorado.

“Aridica Corporation is on a mission to save lives by harnessing the power of the human immune system to cure diseases by developing technologies that accelerate research of cutting edge immunotherapies. The OEDIT grant will significantly help Aridica accelerate our prototyping and testing our early prototypes.”

“Across the state, companies are rethinking existing technologies and inventing new ones within the advanced industries sector. Their success will create good-paying jobs in Colorado and has the potential to change lives across the state and beyond. We are thrilled to be able to support their development and look forward to celebrating future accomplishments.”